Bringing the fundamentals into focus…
Back to LENZ Therapeutics, Inc.
How LENZ Therapeutics, Inc. stacks up
LENZ · against 112 other Healthcare companies of similar size
Profitability
6/ 100
Near the bottom of its peers.
Ranked #94 of 113 · scores higher than 14% of peers
Bars: peers in each 10-point band of the profitability score26 peers with a profitability score of 0–9, including LENZ · Click a bar to see the companies
Why profitability scores 6?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 94% of peers. Operating margin: -631.7% vs peer median 7.1%
- a lower return on assets: weaker than 94% of peers. Return on assets: -53.3% vs peer median 1.7%
- a lower return on invested capital: weaker than 89% of peers. Return on invested capital: -54.9% vs peer median 4.7%
Metric by metric
Position: dot = LENZ, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LENZ | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 81 reported | -54.9% | -13.7% | 29% | 33% | |
| Operating marginHigher is better · 103 reported | -631.7% | -5.9% | 17% | 33% | |
| Return on assetsHigher is better · 119 reported | -53.3% | -6.7% | 9% | 33% | |
| Return on equityHigher is better · 109 reported | -59.2% | -11.8% | 21% | Context only | |
| Gross marginHigher is better · 121 reported | 91.7% | 42.4% | 89% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around LENZ| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 592M ILS (≈$160M) | 96 | 84 | |
| 3 | 157M USD | 95 | ||
| 4 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 5 | 244.2B KRW (≈$176M) | 83 | 72 | |
| 89 | 649M SEK (≈$65M) | 7 | 29 | |
| 89 | 158M USD | 7 | 14 | |
| 89 | 113M USD | 7 | 23 | |
| 94 | 1.1B HKD (≈$141M) | 6 | ||
| 94 | 110M USD | 6 | 54 | |
| 94 | 68M EUR (≈$75M) | 6 | 34 | |
| 94 | 540M ILS (≈$146M) | 6 | 49 | |
| 98 | 10.8B JPY (≈$73M) | 5 | 27 | |
| 98 | 215M USD | 5 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score